{
    "PMC": "5926749",
    "DOI": "10.1111/j.1349-7006.2001.tb01143.x",
    "PMID": "11429053",
    "PMCID": "PMC5926749",
    "title": "Large-scale analysis of mutations in RET exon 16 in sporadic medullary thyroid carcinomas in Japan.",
    "year": 2001,
    "source_url": "https://europepmc.org/article/PMC/PMC5926749",
    "source": "MED",
    "abstract_text": "Germline mutations in the RET proto-oncogene are the cause of multiple endocrine neoplasia type 2 (MEN 2A and 2B) and familial medullary thyroid carcinoma (FMTC). Some cases of sporadic medullary thyroid carcinoma (MTC) have also been reported to have mutations in the RET gene. However, two previous reports have given discrepant results on the frequency of the mutations in RET in sporadic MTCs in Japan. To clarify this problem, we analyzed mutations in RET exon 16 in 72 sporadic MTCs by means of the two methods used in the previous studies, direct sequencing and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Mutations in exon 16 were detected in only 2 of 72 cases of sporadic MTC. These results suggest that when a MTC has a mutation in RET exon 16, it is more likely to be a hereditary MTC than a sporadic one in Japan.",
    "full_text": "Jpn J Cancer Res Jpn. J. Cancer Res 10.1111/(ISSN)1349-7006a CAS Japanese Journal of Cancer Research : Gann 0910-5050 1876-4673 Blackwell Publishing Ltd Oxford, UK 5926749 11429053 10.1111/j.1349-7006.2001.tb01143.x CAE645 Article Large\u2010scale Analysis of Mutations in RET Exon 16 in Sporadic Medullary Thyroid Carcinomas in Japan Takano Torn 1 Miyauchi Akira 2 Yoshida Hiroshi 2 Hasegawa Yukiko 1 Kuma Kanji 2 Amino Nobuyuki 1 1 Department of Laboratory Medicine, Osaka University Medical School, D2 2\u20102 Yamadaoka, Suita, Osaka 565\u20100871 2 Kuma Hospital, 8\u20102\u201035 Simoyamate\u2010dori, Chuo\u2010ku, Kobe, Hyogo 650\u20100011 * To whom correspondence should be addressed. E\u2010mail: ttakano@labo.med.osaka-u.ac.jp 6 2001 92 6 10.1111/cas.2001.92.issue-6 645 648 (Received February 19, 2001/Accepted March 26, 2001) Germline mutations in the RET proto\u2010oncogene are the cause of multiple endocrine neoplasia type 2 (MEN 2A and 2B) and familial medullary thyroid carcinoma (FMTC). Some cases of sporadic medullary thyroid carcinoma (MTC) have also been reported to have mutations in the RET gene. However, two previous reports have given discrepant results on the frequency of the mutations in RET in sporadic MTCs in Japan. To clarify this problem, we analyzed mutations in RET exon 16 in 72 sporadic MTCs by means of the two methods used in the previous studies, direct sequencing and polymerase chain reaction\u2010restriction fragment length polymorphism (PCR\u2010RFLP). Mutations in exon 16 were detected in only 2 of 72 cases of sporadic MTC. These results suggest that when a MTC has a mutation in RET exon 16, it is more likely to be a hereditary MTC than a sporadic one in Japan. Somatic mutation Thyroid medullary carcinoma RET Japanese PCR\u2010RFLP source-schema-version-number 2.0 cover-date June 2001 details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_NLMPMC version:4.6.9 mode:remove_FC converted:04.11.2015 Reference 1 Marsh , D. J. , Learoyd , D. L. and Robinson , B. G. Medullary thyroid carcinoma: recent advances and management update . Thyroid , 5 , 407 \u2013 424 ( 1995 ). 8563482 2 Takahashi , M. , Buma , Y. , Iwamoto , T. , Inaguma , Y. , Ikeda , H. and Hiai , H. Cloning and expression of the ret protooncogene encoding a tyrosine kinase with two potential transmembrane domains . Oncogene , 3 , 571 \u2013 578 ( 1988 ). 3078962 3 Goodfellow , P. J. and Wells , S. A. , Jr. RET gene and its implications for cancer . J. Natl. Cancer Inst. , 87 , 1515 \u2013 1523 ( 1995 ). 7563185 4 Mulligan , L. M. , Kwok , J. B. , Healey , C. S. , Elsdon , M. J. , Eng , C. , Gardner , E. , Love , D. R. , Mole , S. E. , Moore , J. K. , Papi , L. , Ponder , M. A. , Telenius , H. , Tunnacliffe , A. and Ponder , B. A. J. Germ\u2010line mutations of the RET proto\u2010oncogene in multiple endocrine neoplasia type 2A . Nature , 363 , 458 \u2013 460 ( 1993 ). 8099202 5 Mulligan , L. M. , Eng , C. , Healey , C. S. , Clayton , D. , Kwok , J. B. , Gardner , E. , Ponder , M. A. , Frilling , A. , Jackson , C. E. , Lehnert , H. , Neumann , H. P. H. , Thibodeau , S. N. and Ponder , B. A. J. Specific mutations of the RET proto\u2010oncogene are related to disease phenotype in MEN 2A and FMTC . Nat. Genet , 6 , 70 \u2013 74 ( 1994 ). 7907913 6 Carlson , K. M. , Dou , S. , Chi , D. , Scavarda , N. , Toshima , K. , Jackson , C. E. , Wells , S. A. , Jr. , Goodfellow , P. J. and Donis\u2010Keller , H. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B . Proc. Natl. Acad. Sci. USA , 91 , 1579 \u2013 1583 ( 1994 ). 7906417 7 Eng , C. , Smith , D. P. , Mulligan , L. M. , Nagai , M. A. , Healey , C. S. , Ponder , M. A. , Gardner , E. , Scheumann , G. F. , Jackson , C. E. , Tunnacliffe , A. and Ponder , B. A. J. Point mutation within the tyrosine kinase domain of the RET proto\u2010oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours . Hum. Mol. Genet. , 3 , 237 \u2013 241 ( 1994 ). 7911697 8 Hofstra , R. M. , Landsvater , R. M. , Ceccherini , L , Stulp , R. P. , Stelwagen , T. , Luo , Y. , Pasini , B. , Hoppener , J. W. , van Amstel , H. K. , Romeo , G. , Lips , C. J. M. and Buys , C. H. C. M. A mutation in the RET proto\u2010oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma . Nature , 367 , 375 \u2013 376 ( 1994 ). 7906866 9 Komminoth , P. , Kunz , E. K. , Matias\u2010Guiu , X. , Hiort , O. , Christiansen , G. , Colomer , A. , Roth , J. and Heitz , P. U. Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas . Cancer , 76 , 479 \u2013 489 ( 1995 ). 8625130 10 Fink , M. , Weinhusel , A. , Niederle , B. and Haas , O. A. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET protooncogene . Int. J. Cancer , 69 , 312 \u2013 316 ( 1996 ). 8797874 11 Blaugrund , J. E. , Johns , M. M. , Jr. , Eby , Y. J. , Ball , D. W. , Baylin , S. B. , Hruban , R. H. and Sidransky , D. RET protooncogene mutations in inherited and sporadic medullary thyroid cancer . Hum. Mol. Genet. , 3 , 1895 \u2013 1897 ( 1994 ). 7849720 12 Marsh , D. J. , Andrew , S. D. , Eng , C. , Learoyd , D. L. , Capes , A. G. , Pojer , R. , Richardson , A. L. , Houghton , C. , Mulligan , L. M. , Ponder , B. A. and Robinson , B. G. Germ\u2010line and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma . Cancer Res. , 56 , 1241 \u2013 1243 ( 1996 ). 8640806 13 Zedenius , J. , Larsson , C. , Bergholm , U. , Bovee , J. , Svensson , A. , Hallengren , B. , Grimelius , L. , Backdahl , M. , Weber , G. and Wallin , G. Mutations of codon 918 in the RET proto\u2010oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas . J. Clin. Endocrinol. Metab. , 80 , 3088 \u2013 3090 ( 1995 ). 7559902 14 Romei , C. , Elisei , R. , Pinchera , A. , Ceccherini , L , Molinaro , E. , Mancusi , F. , Martino , E. , Romeo , G. and Pacini , F. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence . J. Clin. Endocrinol. Metab. , 81 , 1619 \u2013 1622 ( 1996 ). 8636377 15 Shan , L. , Nakamura , M. , Nakamura , Y. , Utsunomiya , H. , Shou , N. , Jiang , X. , Jing , X. , Yokoi , T. and Kakudo , K. Somatic mutations in the RET protooncogene in Japanese and Chinese sporadic medullary thyroid carcinomas . Jpn. J. Cancer Res. , 89 , 883 \u2013 886 ( 1998 ). 9818022 16 Uchino , S. , Noguchi , S. , Adachi , M. , Sato , M. , Yamashita , H. , Watanabe , S. , Murakami , T. , Toda , M. , Murakami , N. and Yamashita , H. Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas . Jpn. J. Cancer Res. , 89 , 411 \u2013 418 ( 1998 ). 9617347",
    "full_text_abstract": "Germline mutations in the RET proto\u2010oncogene are the cause of multiple endocrine neoplasia type 2 (MEN 2A and 2B) and familial medullary thyroid carcinoma (FMTC). Some cases of sporadic medullary thyroid carcinoma (MTC) have also been reported to have mutations in the RET gene. However, two previous reports have given discrepant results on the frequency of the mutations in RET in sporadic MTCs in Japan. To clarify this problem, we analyzed mutations in RET exon 16 in 72 sporadic MTCs by means of the two methods used in the previous studies, direct sequencing and polymerase chain reaction\u2010restriction fragment length polymorphism (PCR\u2010RFLP). Mutations in exon 16 were detected in only 2 of 72 cases of sporadic MTC. These results suggest that when a MTC has a mutation in RET exon 16, it is more likely to be a hereditary MTC than a sporadic one in Japan."
}